Healio
Avedro Inc. announced it plans on working closely with the U.S. Food and Drug Administration to answer the organization’s questions on its New Drug Application for the riboflavin ophthalmic solution/KXL System.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
OptometryWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.
Learn more about writing for us